Literature DB >> 10918151

A comparison of the Chinese 1992 and fifth-edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma.

M H Hong1, H Q Mai, H Q Min, J Ma, E P Zhang, N J Cui.   

Abstract

BACKGROUND: The Chinese 1992 staging system for nasopharyngeal carcinoma (NPC) has been widely adopted in mainland China since 1992. The fifth edition of the International Union Against Cancer (UICC) TNM classification defines new rules for classifying NPC. The current study compares the two in predicting NPC prognosis.
METHODS: Four hundred eleven NPC patients, most of whom had disease of undifferentiated histologic type and were treated in a constant fashion and with definitive intent with radiation therapy alone, entered this comparative study. The patients were restaged according to the rules of the fifth edition of the UICC staging manual and the Chinese 1992 staging system.
RESULTS: In the opinion of the authors, the predictive power of the Chinese 1992 T classification was superior. Conversely, the authors felt that the UICC N classification was more reasonable. The patients were categorized more evenly by the UICC stages than by the Chinese 1992 stages. The 5-year disease specific survival rates for patients in corresponding stages of both systems were almost identical despite differences in the criteria defining T and N classifications. Statistical analysis showed that the agreement rate was 72%. There were some agreement and correlation between the two staging systems.
CONCLUSIONS: Both systems are essentially similar. Each system appears to have some subtleties that could improve the outcome prediction of the other system if the two were somehow combined. However, it appeared to the authors that the UICC system was slightly better. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Year:  2000        PMID: 10918151     DOI: 10.1002/1097-0142(20000715)89:2<242::aid-cncr6>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

1.  Quality of life of nasopharyngeal carcinoma survivors in Mainland China.

Authors:  Yong Wu; Wei-Han Hu; Yun-Fei Xia; Jun Ma; Meng-Zhong Liu; Nian-Ji Cui
Journal:  Qual Life Res       Date:  2006-10-11       Impact factor: 4.147

Review 2.  The evolution of nasopharyngeal carcinoma staging.

Authors:  Rui Guo; Yan-Ping Mao; Ling-Long Tang; Lei Chen; Ying Sun; Jun Ma
Journal:  Br J Radiol       Date:  2019-07-12       Impact factor: 3.039

Review 3.  Which treatment is better than concurrent chemoradiotherapy about survival for stage III or IV locally advanced nasopharyngeal carcinoma? An updated Bayesian network meta-analysis of randomized controlled trials.

Authors:  Lucheng Fang; Licai Shi; Wen Wang; Tingting Hu; Xingwang Rao
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-17       Impact factor: 2.503

4.  Expression and prognosis of FOXO3a and HIF-1α in nasopharyngeal carcinoma.

Authors:  Zhu Shou; Li Lin; Jia Liang; Jing-Li Li; Hong-Yan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-31       Impact factor: 4.553

5.  Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays.

Authors:  Wenling Zhang; Zhaoyang Zeng; Songqing Fan; Jieru Wang; Jianbo Yang; Yanhong Zhou; Xiayu Li; Donghai Huang; Fang Liang; Minghua Wu; Ke Tang; Li Cao; Xiaoling Li; Wei Xiong; Guiyuan Li
Journal:  J Mol Histol       Date:  2012-03-06       Impact factor: 2.611

6.  Clinicopathologic features and treatment of breast metastasis from nasopharyngeal carcinoma: A report of two cases and literature review.

Authors:  Weiwei Xiao; Zhenyu He; Chao Xing; Wei Zhen; Shaoxiang Wang; Huanxin Lin
Journal:  Oncol Lett       Date:  2015-10-20       Impact factor: 2.967

7.  Prognostic value of interleukin-8 and MMP-9 in nasopharyngeal carcinoma.

Authors:  Daye Cheng; Hong Kong; Yunhui Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-09       Impact factor: 2.503

8.  Aurora-A is an efficient marker for predicting poor prognosis in human nasopharyngeal carcinoma with aggressive local invasion: 208 cases with a 10-year follow-up from a single institution.

Authors:  Zhi-Gang Liu; Wei Yi; Ya-Lan Tao; Hsiao Chang Chan; Mu-Sheng Zeng; Yun-Fei Xia
Journal:  Oncol Lett       Date:  2012-03-27       Impact factor: 2.967

9.  Aurora-A activation, correlated with hypoxia-inducible factor-1α, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma.

Authors:  Xiang-Bo Wan; Xin-Juan Fan; Pei-Yu Huang; Dong Dong; Yan Zhang; Ming-Yuan Chen; Jin Xiang; Jie Xu; Li Liu; Wei-Hua Zhou; Yan-Chun Lv; Xiang-Yuan Wu; Ming-Huang Hong; Quentin Liu
Journal:  Cancer Sci       Date:  2012-07-05       Impact factor: 6.716

10.  Correlation between nasopharyngeal carcinoma tumor volume and the 2002 International Union Against Cancer tumor classification system.

Authors:  Zheng Wu; Mo-Fa Gu; Rui-Fang Zeng; Yong Su; Shao-Min Huang
Journal:  Radiat Oncol       Date:  2013-04-11       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.